A Case of Mixed Connective Tissue Disease That Transformed Into Systemic Lupus Erythematosus After a Long Clinical Course

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 May 30

PMID 37252562

Authors

Fumikazu Sato

Momoka Sato

Takahiro Yamano

Kaori Yamaguchi

Taito Miyake

Affiliations

Soon will be listed here.

Abstract

Mixed connective tissue disease (MCTD), a multisystem autoimmune disease that was first proposed in 1972, has overlapping features with other autoimmune diseases. In recent studies, mixed connective tissue disease has been reported to change into other connective tissue diseases (CTD; such as systemic lupus erythematosus [SLE], polymyositis, and systemic sclerosis [SSc]) in the long term. We report the case of a 58-year-old Japanese man diagnosed with mixed connective tissue disease 15 years ago. During his clinical course, he developed discoid lupus erythematosus, pancytopenia, a low complement titer, proteinuria, and hematuria. He also turned positive for the anti-double-stranded deoxyribonucleic acid (dsDNA) antibody. A kidney biopsy revealed lupus nephritis (LN) class IV. Therefore, we considered this to be a shift from mixed connective tissue disease to systemic lupus erythematosus. We changed his treatment to lupus nephritis, after which he remained in remission. Our case suggests that mixed connective tissue disease may shift to other connective tissue diseases over a long period; therefore, it is necessary to identify whether patients with mixed connective tissue disease fulfill the diagnostic criteria for other connective tissue diseases when new manifestations appear.

Citing Articles

Clinicopathological Analysis and Its Correlation With Various Classes of Lupus Nephritis.

J N, Gunabooshanam B, Balasubramanian S Cureus. 2025; 17(1):e78065.

PMID: 40013193 PMC: 11864095. DOI: 10.7759/cureus.78065.

References

Cappelli S, Bellando Randone S, Martinovic D, Tamas M, Pasalic K, Allanore Y . "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2011; 41(4):589-98. DOI: 10.1016/j.semarthrit.2011.07.010. View

Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund M, Aalokken T . Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study. Arthritis Res Ther. 2017; 19(1):284. PMC: 5740892. DOI: 10.1186/s13075-017-1494-7. View

Gunnarsson R, Molberg O, Gilboe I, Gran J . The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011; 70(6):1047-51. DOI: 10.1136/ard.2010.143792. View

Burdt M, Hoffman R, Deutscher S, Wang G, Johnson J, Sharp G . Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999; 42(5):899-909. DOI: 10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L. View

Sawai T, Murakami K, Kurasono Y . Morphometric analysis of the kidney lesions in mixed connective tissue disease (MCTD). Tohoku J Exp Med. 1994; 174(2):141-54. DOI: 10.1620/tjem.174.141. View

Bajema I, Wilhelmus S, Alpers C, Bruijn J, Colvin R, Cook H . Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018; 93(4):789-796. DOI: 10.1016/j.kint.2017.11.023. View

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R . 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019; 71(9):1400-1412. PMC: 6827566. DOI: 10.1002/art.40930. View

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

Arbuckle M, McClain M, Rubertone M, Scofield R, Dennis G, James J . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16):1526-33. DOI: 10.1056/NEJMoa021933. View

10.

Sharp G, Irvin W, Tan E, Gould R, HOLMAN H . Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972; 52(2):148-59. DOI: 10.1016/0002-9343(72)90064-2. View

11.

Parikh S, Almaani S, Brodsky S, Rovin B . Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis. 2020; 76(2):265-281. DOI: 10.1053/j.ajkd.2019.10.017. View

12.

Kostopoulou M, Fanouriakis A, Cheema K, Boletis J, Bertsias G, Jayne D . Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations. RMD Open. 2020; 6(2). PMC: 7425195. DOI: 10.1136/rmdopen-2020-001263. View

13.

Hannah J, Casian A, DCruz D . Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. Autoimmun Rev. 2015; 15(1):93-101. DOI: 10.1016/j.autrev.2015.09.006. View

14.

Ungprasert P, Crowson C, Chowdhary V, Ernste F, Moder K, Matteson E . Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study. Arthritis Care Res (Hoboken). 2016; 68(12):1843-1848. PMC: 5426802. DOI: 10.1002/acr.22872. View

15.

Pepmueller P . Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology. Mo Med. 2016; 113(2):136-40. PMC: 6139943. View